Roche is a global company at the forefront of drug and diagnostic discovery and development, focused on enabling people to live better, longer lives through scientific advances. By combining pharmaceuticals and diagnostics under one roof, Roche is a leader in personalized medicine - a strategy that aims to provide every patient with the best possible treatment.
Roche is the largest biotech company in the world with differentiated medicines for oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the leading provider of in vitro diagnostics and tissue-based cancer testing and a pioneer in diabetes management.
Since its founding in 1896, Roche has been researching better ways to prevent, detect and treat diseases and making a lasting contribution to social development. The company's goal is to improve patients' access to medical innovations through cooperation with all relevant partners. There are now 30 medicines developed by Roche on the World Health Organization's list of essential medicines, including life-saving antibiotics, antimalarials and cancer drugs. Roche was also recognized as the most sustainable company within the pharmaceutical, biotechnology and life sciences industries in the Dow Jones Sustainability Index for the ninth year in a row.
The Roche Group, headquartered in Basel, Switzerland, operates in over 100 countries and employed around 94,000 people worldwide in 2017. In 2017, Roche invested CHF 10.4 billion in research and development and achieved sales of CHF 53.3 billion. Genentech in the USA is wholly owned by the Roche Group. Roche is the majority shareholder of Chugai Pharmaceutical, Japan. For more information, see .
All brand names mentioned are protected by law.
Further information on:
Roche careers page
Roche career blog
Roche on social networks
